Affiliation:
1. Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA
2. Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA
3. Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92697, USA
Abstract
Small cell lung cancer (SCLC) is a deadly neuroendocrine malignancy, notorious for its rapid tumor growth, early metastasis, and relatively “cold” immune environment. Only standard chemotherapies and a few immune checkpoint inhibitors have been approved for SCLC treatment, revealing an urgent need for novel therapeutic approaches. Moreover, SCLC has been recently recognized as a malignancy with high intratumoral and intertumoral heterogeneity, which explains the modest response rate in some patients and the early relapse. Molecular subtypes defined by the expression of lineage-specific transcription factors (ASCL1, NEUROD1, POU2F3, and, in some studies, YAP1) or immune-related genes display different degrees of neuroendocrine differentiation, immune cell infiltration, and response to treatment. Despite the complexity of this malignancy, a few biomarkers and targets have been identified and many promising drugs are currently undergoing clinical trials. In this review, we integrate the current progress on the genomic landscape of this shapeshifting malignancy, the characteristics and treatment vulnerabilities of each subtype, and promising drugs in clinical phases.
Funder
American Lung Association
Reference104 articles.
1. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Bray;CA A Cancer J. Clin.,2018
2. (2021, May 04). The American Cancer Society Medical and Editorial Content Team What Is Lung Cancer?|Types of Lung Cancer. Available online: https://www.cancer.org/cancer/lung-cancer/about/what-is.html.
3. Cittolin-Santos, G.F., Knapp, B., Ganesh, B., Gao, F., Waqar, S., Stinchcombe, T.E., Govindan, R., and Morgensztern, D. (2024). The Changing Landscape of Small Cell Lung Cancer. Cancer.
4. Neuroendocrine Tumors of the Lung;Demes;Cancers,2012
5. Recent Progress in Mapping the Emerging Landscape of the Small Cell Lung Cancer Genome;Kim;Exp. Mol. Med.,2019